The DOI matches its Crossref record; 64 of the 68 references it cites were found in a registry or an index.
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Abstract
The anatomical distribution and density of cannabinoid receptors in the human brain was studied in one fetal (33 weeks gestation), two neonatal (aged three to six months) and eight adult (aged 21-81 years) human cases using quantitative receptor autoradiography following in vitro labelling of sections with the synthetic cannabinoid agonist [3H]CP55,940. Cannabinoid receptors were distributed in a heterogeneous fashion throughout the adult human brain and spinal cord. The allocortex contained very high concentrations of cannabinoid receptor binding sites in the dentate gyrus, Ammons's horn and subiculum of the hippocampal formation; high concentrations of receptors were also present in the entorhinal cortex and amygdaloid complex. Cannabinoid receptor binding sites were also present throughout all regions of the neocortex, where they showed a marked variation in density between the primary, secondary and associational cortical regions: the greatest densities of receptors were present in the associational cortical regions of the frontal and limbic lobes, with moderate densities in the secondary sensory and motor cortical regions, and with the lowest densities of receptors in the primary sensory and motor cortical regions. Relatively high concentrations of cannabinoid receptors were consistently seen in cortical regions of the left (dominant) hemisphere, known to be associated with verbal language functions. In all of the cortical regions, the pattern and density of receptor labelling followed the neocortical laminar organization, with the greatest density of receptors localized in two discrete bands--a clearly delineated narrow superficial band which coincided with lamina I and a deeper broader, conspicuous band of labelling which corresponded to laminae V and VI. Labelling in the intervening cortical laminae (II-IV) showed lower densities, with a well delineated narrow band of label in the middle of laminae IV in the associational cortical regions. The thalamus showed a distinctive heterogeneous distribution of cannabinoid receptors, with the highest concentration of receptors localized in the mediodorsal nucleus, anterior nuclear complex, and in the midline and intralaminar complex of nuclei, i.e. in thalamic nuclei which have connectional affiliations with the associational cortical areas. The basal ganglia showed a distinctive heterogeneous pattern of receptor binding, with the very highest concentrations in the globus pallidus internus, moderate concentrations in the globus pallidus externus and ventral pallidum, and moderately low levels of binding throughout the striatal complex. In the midbrain, some of the highest levels of cannabinoid receptor binding sites in the human brain were present in the substantia nigra pars reticulata, with very low levels of labelling in all other midbrain areas. The highest densities of cannabinoid receptor binding in the hindbrain were localized in the molecular layer of the cerebellar cortex and the dorsal motor nucleus of the vagus, with moderate densities of receptors in the nucleus of the solitary tract. The spinal cord showed very low levels of receptor binding. Studies on the distribution of cannabinoid receptors in the fetal and neonatal human brain showed similar patterns of receptor distribution to that observed in the adult human brain, except that the density of receptor binding was generally markedly higher, especially in the basal ganglia and substantia nigra. The pattern of cannabinoid receptor labelling in the striatum showed a striking patchy pattern of organization which was especially conspicuous in the fetal brain. These results show that cannabinoid receptor binding sites in the human brain are localized mainly in: forebrain areas associated with higher cognitive functions; forebrain, midbrain and hindbrain areas associated with the control of movement; and in hindbrain areas associated with the control of motor and sensory functions of the autonomic nervous system. (AB
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CB1 receptors are the most abundant G-protein-coupled receptors in the central nervous system12, 13”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [12]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Jones, E. G. (1985) · Springer eBooks · doi:10.1007/978-1-4615-1749-8 · Cited by 1,164
Graybiel, A. M., & Ragsdale, C. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5723 · Cited by 784
Laminar Organization of Thalamic Projections to the Rat Neocortex
Herkenham, M. A. (1980) · Science · doi:10.1126/science.7352263 · Cited by 595
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500
Research works printed but not linked: 9
- Bidaut-Russell, 1989, Opioid and cannabinoid analgetics both inhibit cyclic AMP production in the rat striatum, Adv. Biosci., 75, 165
- Campbell, 1986, Delta-9-tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat detate gyrus, J. Pharmac. exp. Ther., 239, 941
- Chen, 1993, Transient concentration of cannabinoid receptors in the cortex subplate zone during kitten post-natal development, Soc. Neurosci. Abstr., 19, 305
- Devane, 1988, Determination and characterisation of a cannabinoid receptor in rat brain, Molec. Pharmac., 34, 605
- Dewey, 1972, The effects of chronic administration of trans-delta-9-tetrahydorcannibinol on behaviour and the cardiovascular system of dogs, Archs int. Pharmacodyn. Thér., 198, 118
- Edery, 1972, Structure activity relationships in the tetrahydrocanabinol species, Arzneimittel-Forshch., 22, 1995
- Howlett, 1985, Cannabinoid inhibition of adenylate cyclase. Biochemistry of response in neuroblasta cell membrane, Molec. Pharmac., 27, 429
- Howlett, 1986, Involvement of Gi in the inhibition of adenylate cyclase by cannabinoid drugs, Molec. Pharmac., 29, 307
- Mendelson, 1976, Operant acquisition of marijuana by men, J. Pharmac. exp. Ther., 198, 42
Cited by
Sorted by citations
Items 401–500 of 1,000
Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice
Cavener, V. S., Gaulden, A. D., Pennipede, D., Jagasia, P., Uddin, J., Marnett, L. J., & Patel, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00479 · Cited by 43
Lawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 44
Multiple sclerosis, cannabis, and cognition: A structural MRI study
Romero, K., Pavisian, B., Staines, R. W., & Feinstein, A. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.04.006 · Cited by 41
Cannabinoid Receptors and Their Relationships with Neuropsychiatric Disorders
Gambi, F., Berardis, D. D., Sepede, G., Quartesan, R., Calcagni, E., Salerno, R. M., Conti, C. M., & Ferro, F. M. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800103 · Cited by 41
Hurst, D. P., Schmeisser, M. G., & Reggio, P. H. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.01.009 · Cited by 42
Dronabinol and chronic pain: importance of mechanistic considerations
de Vries, M., van Rijckevorsel, D. C., Wilder‐Smith, O. H. G., & van Goor, H. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.918102 · Cited by 40
Zabik, N. L., Iadipaolo, A. S., Marusak, H. A., Peters, C., Burghardt, K. J., & Rabinak, C. A. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24860 · Cited by 44
Darmani, N. A., & Crim, J. L. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.019 · Cited by 40
Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 41
The Endocannabinoid System: A Putative Role in Neurodegenerative Diseases
Iorio, G. D., Lupi, M., Sarchione, F., Matarazzo, I., Santacroce, R., Petruccelli, F., Martinotti, G., & Giannantonio, M. D. (2013) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.9222 · Cited by 39
Durieux, L. J. A., Gilissen, S. R. J., & Arckens, L. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15110 · Cited by 40
Dennis, I. F., Whalley, B., & Stephens, G. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.190 · Cited by 39
Effects of Marijuana Use on Brain Structure and Function
Brumback, T., Castro, N., Jacobus, J., & Tapert, S. F. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.06.004 · Cited by 38
Kranaster, L., Hoyer, C., Aksay, S. S., Bumb, J. M., Leweke, F. M., Janke, C., Thiel, M., Lutz, B., Bîndilă, L., & Sartorius, A. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0789-7 · Cited by 41
Imaging in Parkinson's Disease
Politis, M., Pagano, G., & Niccolini, F. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.02.015 · Cited by 39
Visual scan paths in first-episode schizophrenia and cannabis-induced psychosis
Benson, P. J., Leonards, U., Lothian, R., Clair, D. M. S., & Merlo, M. C. G. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0727 · Cited by 38
GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia
Volk, D. W., & Lewis, D. A. (2005) · Current Neuropharmacology · doi:10.2174/1570159052773396 · Cited by 38
Vinod, K. Y., & Hungund, B. L. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.041 · Cited by 38
Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders
Vinod, K. Y., & Hungund, B. L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.2.203 · Cited by 38
Wright, N., Scerpella, D., & Lisdahl, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166005 · Cited by 38
Distinct functions of endogenous cannabinoid system in alcohol abuse disorders
Basavarajappa, B. S., Joshi, V., Shivakumar, M., & Subbanna, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14780 · Cited by 37
Presynaptic and extrasynaptic regulation of posterior nucleus of thalamus
Park, A., Li, Y., Masri, R. M., & Keller, A. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00862.2016 · Cited by 37
No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophrenia
Deng, C., Han, M., & Huang, X. (2007) · Neuroscience Bulletin · doi:10.1007/s12264-007-0051-9 · Cited by 37
Papini, S., Sullivan, G. M., Hien, D. A., Shvil, E., & Neria, Y. (2014) · Biological Psychology · doi:10.1016/j.biopsycho.2014.10.010 · Cited by 37
Cannabinoids and experimental models of multiple sclerosis
Kubajewska, I., & Constantinescu, C. S. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.08.004 · Cited by 37
Alterations of Monetary Reward and Punishment Processing in Chronic Cannabis Users: An fMRI Study
Enzi, B., Lissek, S., Edel, M., Tegenthoff, M., Nicolas, V., Scherbaum, N., Juckel, G., & Roser, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119150 · Cited by 37
Aberrant structural–functional coupling in adult cannabis users
Kim, D., Martin, A. M. S., Shin, Y., Jo, H. J., Cheng, H., Newman, S. D., Sporns, O., Hetrick, W. P., Calkins, E., & O’Donnell, B. F. (2018) · Human Brain Mapping · doi:10.1002/hbm.24369 · Cited by 40
The Potential of Cannabinoid-Based Treatments in Tourette Syndrome
Artukoglu, B. B., & Bloch, M. H. (2019) · CNS Drugs · doi:10.1007/s40263-019-00627-1 · Cited by 39
Karoly, H. C., Mueller, R. L., Bidwell, L. C., & Hutchison, K. E. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14256 · Cited by 37
Kim, D., Skosnik, P. D., Cheng, H., Pruce, B., Brumbaugh, M. S., Vollmer, J. M., Hetrick, W. P., O’Donnell, B. F., Sporns, O., Puce, A., et al. (2011) · Brain Connectivity · doi:10.1089/brain.2011.0053 · Cited by 38
Bereiter, D. A., Bereiter, D. A., & Hirata, H. (2002) · Pain · doi:10.1016/s0304-3959(02)00271-3 · Cited by 37
Qian, W., Yin, N., Gao, F., Miao, Y., Li, Q., Li, F., Sun, X., Yang, X., & Wang, Z. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.027 · Cited by 37
Autoradiography of receptor-activated G-proteins in post mortem human brain
Rodríguez‐Puertas, R., González‐Maeso, J., Meana, J. J., & Pazos, Á. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00527-8 · Cited by 37
Are cannabinoid receptor knockout mice animal models for schizophrenia?
Fritzsche, M. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1261 · Cited by 37
Cannabinoids: Potential Targets for Bladder Dysfunction
Ruggieri, M. R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-16499-6_20 · Cited by 36
Mechanisms contributing to cognitive deficits in cannabis users
Mizrahi, R., Watts, J. J., & Tseng, K. Y. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.018 · Cited by 36
Biased agonism at the cannabinoid receptors – Evidence from synthetic cannabinoid receptor agonists
Patel, M., Finlay, D. B., & Glass, M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109865 · Cited by 36
Self-citationLongoria, V., Parcel, H., Toma, B., Minhas, A., & Zeine, R. R. (2022) · Biomedicines · doi:10.3390/biomedicines10030539 · Cited by 36
Cannabinoids, interoception, and anxiety
Andrade, A. K., Renda, B., & Murray, J. E. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.03.006 · Cited by 41
Decision Making and Impulsivity in Young Adult Cannabis Users
O'Donnell, B. F., Skosnik, P. D., Hetrick, W. P., & Fridberg, D. J. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.679904 · Cited by 41
Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease
Wang, M., Liu, H., & Ma, Z. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.832854 · Cited by 36
Giuffrida, A., & McMahon, L. R. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.05.004 · Cited by 40
Organization of Human Brain Stem Nuclei
Koutcherov, Y., Huang, X., Halliday, G. M., & Paxinos, G. (2004) · Elsevier eBooks · doi:10.1016/b978-012547626-3/50011-9 · Cited by 35
Ritchay, M. M., Huggins, A. A., Wallace, A. L., Larson, C. L., & Lisdahl, K. M. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102664 · Cited by 36
Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence
Chye, Y., Kirkham, R., Lorenzetti, V., McTavish, E., Solowij, N., & Yücel, M. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.07.009 · Cited by 34
Manning, J. J., Green, H. M., Glass, M., & Finlay, D. B. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108611 · Cited by 37
Self-citationRecent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential
Gasperi, V., Guzzo, T., Topai, A., Gambacorta, N., Ciriaco, F., Nicolotti, O., & Maccarrone, M. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220825161603 · Cited by 34
Castle, D. J., & Ames, F. R. (1996) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679609076093 · Cited by 34
Tsujikawa, T., Zoghbi, S. S., Hong, J. S., Donohue, S. R., Jenko, K. J., Gladding, R. L., Halldin, C., Pike, V. W., Innis, R. B., & Fujita, M. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.09.043 · Cited by 34
Silva, L., Harte‐Hargrove, L. C., Izenwasser, S., Frank, A., Wade, D., & Dow-Edwards, D. L. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.06.033 · Cited by 34
Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis
Nottage, J. F., Stone, J. M., Murray, R. M., Sumich, A. L., Bramon, E., Ffytche, D. H., & Morrison, P. D. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3684-1 · Cited by 33
Silveri, M. M., Jensen, J. E., Rosso, I. M., Sneider, J. T., & Yurgelun-Todd, D. A. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.10.005 · Cited by 33
Sagar, K. A., & Gruber, S. A. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13990 · Cited by 36
Lisano, J. K., Kisiolek, J. N., Smoak, P., Phillips, K. T., & Stewart, L. K. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0300 · Cited by 33
Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi‐Puttini, P., Batticciotto, A., Atzeni, F., Bazzichi, L. M., Franco, M. D., Salaffi, F., Marotto, D., Ceribelli, A., Ablin, J. N., & Häuser, W. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1665997 · Cited by 34
Glodosky, N. C., Cuttler, C., Freels, T. G., Wright, H. R., Rojas, M. J., Baglot, S. L., Hill, M. N., & McLaughlin, R. J. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100260 · Cited by 35
The acute and non-acute effects of cannabis on reward processing: A systematic review
Skumlien, M., Langley, C., Lawn, W., Voon, V., Curran, H. V., Roiser, J. P., & Sahakian, B. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.008 · Cited by 38
Ashton, J. C., Zheng, Y., Liu, P., Darlington, C. L., & Smith, P. F. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.065 · Cited by 33
Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users
Chye, Y., Suo, C., Yücel, M., Ouden, L. D., Solowij, N., & Lorenzetti, V. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4620-y · Cited by 32
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data
Walther, S., & Halpern, M. (2010) · Pharmaceuticals · doi:10.3390/ph3082689 · Cited by 32
Hoot, M. R., Sim‐Selley, L. J., Poklis, J. L., Abdullah, R. A., Scoggins, K. L., Selley, D. E., & Dewey, W. L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.105 · Cited by 34
Role of cannabinoid receptors in the control of gastrointestinal motility and perception
Fioramonti, J., & Bueno, L. P. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.3.385 · Cited by 32
Cannabinoids for Neuropathic Pain
Fine, P. G., & Rosenfeld, M. J. (2014) · Current Pain and Headache Reports · doi:10.1007/s11916-014-0451-2 · Cited by 32
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers
Ayakannu, T., Taylor, A. H., Marczylo, T. H., Willets, J. M., & Konje, J. C. (2013) · International Journal of Endocrinology · doi:10.1155/2013/259676 · Cited by 32
Estrada, J. A., & Contreras, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200217140255 · Cited by 33
Ploner, C. J. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.10.1016 · Cited by 32
Comorbid Mood, Psychosis, and Marijuana Abuse Disorders: A Theoretical Review
Wilson, N., & Cadet, J. L. (2009) · Journal of Addictive Diseases · doi:10.1080/10550880903182960 · Cited by 33
Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system
Wyrofsky, R. R., Reyes, B. A. S., Zhang, X.-Y., Bhatnagar, S., Kirby, L. G., & Bockstaele, E. J. V. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100176 · Cited by 31
Cortico-cerebellar abnormalities in adolescents with heavy marijuana use
Lopez-Larson, M. P., Rogowska, J., Bogorodzki, P., Bueler, C. E., McGlade, E., & Yurgelun-Todd, D. A. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.11.005 · Cited by 31
Boggs, D. L., Cortes-Briones, J., Surti, T. S., Luddy, C., Ranganathan, M., Cahill, J. D., Sewell, A., D’Souza, D. C., & Skosnik, P. D. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118799953 · Cited by 31
FOXN3 and GDNF Polymorphisms as Common Genetic Factors of Substance Use and Addictive Behaviors
Vereczkei, A., Barta, C., Mägi, A., Farkas, J., Eisinger, A., Király, O., Belik, A. A., Griffiths, M. D., Székely, A., Sasvári‐Székely, M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050690 · Cited by 31
Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor
Ndong, C., O’Donnell, D., Ahmad, S., & Groblewski, T. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.002 · Cited by 30
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors
Belmont, O. A., Romano‐López, A., Ruiz‐Contreras, A. E., Méndez‐Díaz, M., & Prospero-Garcia, O. E. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22472 · Cited by 32
Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
Nagy-Grócz, G., Zádor, F., Dvorácskó, S., Bohár, Z., Benyhe, S., Tömböly, C., Párdutz, Á., & Vécsei, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081617 · Cited by 30
Endocannabinoid System and Alcohol Abuse Disorders
Basavarajappa, B. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21737-2_6 · Cited by 32
Moranta, D., Esteban, S., & Garcı́a-Sevilla, J. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21140 · Cited by 30
Harkany, T., Dobszay, M. B., Cayetanot, F., Härtig, W., Siegemund, T., Aujard, F., & Mackie, K. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.043 · Cited by 30
A Review of Magnetic Resonance Spectroscopy Studies in Marijuana using Adolescents and Adults
Mashhoon, Y. (2013) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s4-010 · Cited by 29
Dow-Edwards, D. L., Frank, A., Wade, D., Weedon, J., & Izenwasser, S. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.09.004 · Cited by 33
The Effects of Cannabis Use on Cognitive Function in Healthy Aging: A Systematic Scoping Review
Pocuca, N., Walter, T. J., Minassian, A., Young, J. W., Geyer, M. A., & Perry, W. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaa105 · Cited by 31
Crombie, K. M., Privratsky, A. A., Schomaker, C. M., Heilicher, M. O., Ross, M. C., Sartin‐Tarm, A., Sellnow, K. A., Binder, E. B., James, G. A., & Cisler, J. M. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102922 · Cited by 33
Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond
Hempel, B. J., & Xi, Z. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.006 · Cited by 29
Mechanisms Underlying the Link between Cannabis Use and Prospective Memory
Cuttler, C., McLaughlin, R. J., & Graf, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036820 · Cited by 30
Gonsiorek, W., Hesk, D., Chen, S., Kinsley, D., Fine, J. S., Jackson, J. V., Bober, L. A., Deno, G., Bian, H., Fossetta, J. D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602364200 · Cited by 29
Targeting the Endocannabinoid System in Psychiatric Illness
Katzman, M. A., Furtado, M., & Anand, L. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000581 · Cited by 30
Long-term effects of cannabis on oculomotor function in humans
Huestegge, L., Radach, R. R., & Kunert, H. J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108091601 · Cited by 29
Exploring causal mechanisms of psychosis risk
Oliver, D., Chesney, E., Cullen, A. E., Davies, C., Englund, A., Gifford, G., Kerins, S., Lalousis, P. A., Logeswaran, Y., Merritt, K., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105699 · Cited by 33
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Pagano, G., Yousaf, T., & Politis, M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0794-2 · Cited by 28
Rossetti, M. G., Mackey, S., Patalay, P., Allen, N. B., Batalla, A., Bellani, M., Chye, Y., Conrod, P., Cousijn, J., Garavan, H., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01382-y · Cited by 29
A review of the effects of acute and chronic cannabinoid exposure on the stress response
Glodosky, N. C., Cuttler, C., & McLaughlin, R. J. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100945 · Cited by 31
Cannabis and Cannabinoids in the Perioperative Period
Lee, B. H., Sideris, A., Ladha, K. S., Johnson, R. L., & Wu, C. L. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006070 · Cited by 29
Niloy, N., Hediyal, T. A., Vichitra, C., Sharma, S., Chidambaram, S. B., Gorantla, V. R., & Mahalakshmi, A. M. (2023) · Biomolecules · doi:10.3390/biom13010162 · Cited by 28
Physical exercise in adolescence changes CB1 cannabinoid receptor expression in the rat brain
da Silva, S. G., Araújo, B. H. S., Cossa, A. C., Scorza, F. A., Cavalheiro, É. A., Naffah‐Mazzacoratti, M. D. G., & Arida, R. M. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.07.001 · Cited by 28
García‐García, F., Acosta-Peña, E., Venebra-Muñoz, A., & Murillo‐Rodríguez, E. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709788921672 · Cited by 28
Dang, D.-K., Shin, E., Mai, A.-T., Jang, C., Nah, S.-Y., Jeong, J. H., Ledent, C. A., Yamamoto, T., Nabeshima, T., Onaivi, E. S., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.033 · Cited by 28
Impaired contrast sensitivity at low spatial frequency in cannabis users with early onset
Lalanne, L., Devouge, E. F., Kirchherr, S., Rauch, L., Koning, E., Speeg, C., Laprévote, V., & Giersch, A. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.09.006 · Cited by 28
Endocannabinoids: Stress, Anxiety, and Fear
Taber, K. H., & Hurley, R. A. (2009) · Journal of Neuropsychiatry · doi:10.1176/jnp.2009.21.2.iv · Cited by 27
Cawston, E. E., Connor, M. A., Marzo, V. D., Silvestri, R., & Glass, M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00579 · Cited by 27
Self-citationMedicinal Cannabis and Central Nervous System Disorders
Ortiz, Y. T., McMahon, L. R., & Wilkerson, J. L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.881810 · Cited by 29
Metadata
- Authors
- Glass, M., Faull, R. L. M., & Dragunow, M.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Faull, R.L.M
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1997-02
- Volume
- 77
- Issue
- 2
- Pages
- 299-318
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2037811574
- Cited by
- 1,052
- References
- 68
- Citations by year
- 2026: 28 · 2025: 40 · 2024: 34 · 2023: 39 · 2022: 56 · 2021: 53 · 2020: 52 · 2019: 48 · 2018: 46 · 2017: 49 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 42
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- cannabinoid receptors, human brain, receptor distribution, receptor density, fetal brain, neonatal brain, hippocampal formation, neocortex, cortical laminar organization, thalamus, basal ganglia, midbrain, spinal cord, globus pallidus internus, globus pallidus externus, ventral pallidum, striatum, amygdala, entorhinal cortex, hemispheric lateralization, CP55,940
- MeSH terms
- Adult, Aged, Aged, 80 and over, Autoradiography, Brain, Brain Chemistry, Brain Mapping, Cannabinoids, Coloring Agents, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myelin Sheath, Pregnancy, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
